Vraylar vs. Eskalith (Lithium)

Are Vraylar and Eskalith (Lithium) the Same Thing?

Vraylar (cariprazine) and Eskalith (Lithium) are used to treat manic episodes associated with bipolar disorder.

Vraylar is also used to treat schizophrenia, and for the acute treatment of mixed episodes associated with bipolar I disorder.

Eskalith (Lithium) is also indicated as a maintenance treatment for individuals with a diagnosis of bipolar disorder.

Vraylar and Eskalith (Lithium) belong to different drug classes. Vraylar is an atypical antipsychotic and Eskalith (Lithium) is an antimanic agent.

Side effects of Vraylar and Eskalith (Lithium) that are similar include vomiting, sleepiness/drowsiness, and diarrhea.

Side effects of Vraylar that are different from Eskalith (Lithium) include extrapyramidal symptoms (muscle spasms, muscle rigidity, tremor, jerking movements), agitation, indigestion, nausea, restlessness, weight gain, headache, insomnia, abdominal pain, constipation, toothache, anxiety, pain in the extremities, dry mouth, loss of appetite, back pain, dizziness, and cough.

Side effects of Eskalith (Lithium) that are different from Vraylar include hand tremors, increased urination, mild thirst, muscle weakness, lack of coordination, giddiness, weakness, blurred vision, and ringing in the ears.

Both Vraylar and Eskalith (Lithium) may interact with carbamazepine.

Vraylar may also interact with CYP3A4 inducers carbamazepine, and inhibitors.

Eskalith (Lithium) may also interact with diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), acetazolamide, urea, xanthine preparations, alkalinizing agents such as sodium bicarbonate, iodide preparations, calcium channel blockers, metronidazole, fluoxetine, and nonsteroidal anti-inflammatory drugs (NSAIDs).

What Are Possible Side Effects of Vraylar?

Side effects of Vraylar include:

  • extrapyramidal symptoms (muscle spasms, muscle rigidity, tremor, jerking movements),
  • agitation,
  • indigestion,
  • nausea,
  • vomiting,
  • sleepiness,
  • restlessness,
  • weight gain,
  • headache,
  • insomnia,
  • abdominal pain,
  • constipation,
  • toothache,
  • anxiety,
  • diarrhea,
  • pain in the extremities,
  • dry mouth,
  • loss of appetite,
  • back pain,
  • dizziness, and
  • cough.

What Are Possible Side Effects of Eskalith (Lithium)?

Common side effects of Eskalith (Lithium) include:

  • mild hand tremor,
  • weakness,
  • lack of coordination,
  • dry mouth,
  • altered taste perception,
  • weight gain,
  • increased thirst,
  • increased frequency of urination,
  • mild nausea or vomiting,
  • loss of appetite,
  • stomach pain or upset,
  • impotence,
  • decreased libido,
  • diarrhea,
  • thinning or drying of the hair,
  • itching skin, and
  • kidney abnormalities.

What Is Vraylar?

Vraylar (cariprazine) is an atypical antipsychotic indicated for the treatment of schizophrenia, and the acute treatment of manic or mixed episodes associated with bipolar I disorder.

What Is Eskalith (Lithium)?

Eskaltih (lithium) is an antimanic agent used for treating manic episodes due to bipolar disorder. Eskaltih is also combined with antidepressants to treat depression.

SLIDESHOW

What Is Bipolar Disorder? Symptoms, Manic Episodes, Testing See Slideshow

What Drugs Interact With Vraylar?

Vraylar may interact with CYP3A4 inducers and inhibitors. Tell your doctor all medications and supplements you use.

What Drugs Interact With Eskalith (Lithium)?

Lithium interacts with non-steroidal anti-inflammatory drugs (NSAIDs), hydrochlorothiazide, ACE inhibitors, and methyldopa. Eskaltih can cause harm to a fetus. Do not use Eskaltih without your doctor's consent if you are pregnant. Tell your doctor if you become pregnant during treatment with Eskaltih.

How Should Vraylar Be Taken?

The starting dose of Vraylar is 1.5 mg once daily.

How Should Eskalith (Lithium) Be Taken?

Lithium doses vary widely and are adjusted based on measurements of the levels of lithium in the blood. Most patients require 900-1200 mg daily in 2-3 divided doses.

QUESTION

Another term that has been previously used for bipolar disorder is ___________________. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References

Allergan. Vraylar Drug Information.
https://www.vraylar.com
FDA. Eskalith Drug Information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/16860slr074,18152slr020_eskalith_lbl.pdf

Health Solutions From Our Sponsors